Corxel Pharmaceuticals
Corxel Pharmaceuticals develops clinical-stage medicines for cardiometabolic diseases, including obesity, diabetes, stroke and hypertension.
≤$287MSeries D1
ParticipantRI
RTW Investments
Activity from announced rounds
Activity in this selectionChina · Oct 25, 2026 · Jan 1, 2026
RTW Investments is the investment manager named in Amani and Encoded financing histories.
Recorded funding activity
Amani develops combination medicines for neuropsychiatric disorders. Encoded develops gene-regulation therapies for neurological disease. The histories refer to the manager rather than a specified RTW fund.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share